Researcher
Paul Cos
- Research Expertise:In vitro and in vivo biofilm assays, Integrated antimicrobial (bacteria, fungi, yeasts and parasites) screening and profiling of pure compounds and extracts, targeting redox homeostasis in mycobacteria
- Keywords:MICROBIOLOGY, BACTERIOLOGY, BIOFILMS, INFLAMMATION, Pharmacy and pharmacology
- Disciplines:Microbiology, Systems biology, Laboratory medicine
- Research techniques:In vitro and in vivo (pre-clinical) models of infectious diseases (bacteria and fungi), evaluation of drugs
- Users of research expertise:Pharmaceutical companies (big pharma, SME, spin-off), news agencies, journalists, government agencies, regulatory (EU) agencies, non-governmental organisations in the field of infectious diseases
Affiliations
- Laboratory for Microbiology, Parasitology and Hygiene (LMPH) (Research group)
Responsible
From1 Oct 2020 → Today - Laboratory for Microbiology, Parasitology and Hygiene (LMPH) (Research group)
Member
From1 Oct 2006 → 30 Sep 2020
Projects
1 - 10 of 59
- SEP BOF 2022 - DelNAM PlusFrom1 Dec 2022 → TodayFunding: BOF - projects
- Prevention of ventilator-associated pneumonia: analysis of the in vitro and in vivo anti-biofilm capacity of cecropin-based coatings on endotracheal tubes.From1 Nov 2022 → TodayFunding: FWO fellowships
- Chemical probes for imaging bacterial proteases in lung infections.From1 Nov 2022 → TodayFunding: BOF - postdoctoral mandates
- Respiratory co-infection models for fundamental and translational biomedical research.From1 Nov 2022 → TodayFunding: BOF - postdoctoral mandates
- Infrastructure for Diverse Applications of Single Cell Sorting and Dispensing using Microfluidics.From1 Jun 2022 → TodayFunding: BOF - scientific equipment program
- Implementation of in vivo models to identify potential candidates for treatment of Dry Eye DiseaseFrom1 Oct 2021 → 30 Sep 2022Funding: BOF - projects
- Persistence in Streptococcus pneumoniae infections: elucidation of the importance of persister cells in chronic and recurrent infectionsFrom1 Nov 2020 → TodayFunding: FWO fellowships
- In vivo evaluation of biofilm-related pneumonia.From1 Oct 2020 → 30 Sep 2021Funding: BOF - projects
- Springboard for excellence in advanced development of antibacterials (SPRINGBOARD).From1 Sep 2020 → TodayFunding: H2020-EU.4. - Spreading excellence and widening participation
- 3D printing of drug loaded medical devices for personalized medicine.From1 May 2020 → 30 Apr 2022Funding: IOF - technology concept exploration
Publications
211 - 220 of 272
- Intrinsic susceptibility of **Giardia duodenalis** assemblage subtypes $A_{I}$, $A_{II}$, B and $E_{III}$ for nitric oxide under axenic culture conditions(2012)
Authors: Ely Bénéré, Tim Van Assche, Paul Cos, Louis Maes
Pages: 1315 - 1319 - In vitro antiplasmodial, antileishmanial and antitrypanosomal activities of selected medicinal plants used in the traditional Arabian Peninsular region(2012)
Authors: Nawal M. al- Musayeib, Ramzi A. Mothana, Paul Cos, Louis Maes
- Study of the **in vitro** antiplasmodial, antileishmanial and antitrypanosomal activities of medicinal plants from Saudi Arabia(2012)
Authors: Nawal M. al- Musayeib, Ramzi A. Mothana, Shaza al- Massarani, Paul Cos, Louis Maes
Pages: 11379 - 11390 - In vitro antimicrobial assessment of Cuban propolis extracts(2012)
Authors: Lianet Monzote, Osmany Cuesta-Rubio, Mercedes Campo Fernandez, Ingrid Márquez Hernandez, Jorge Fraga, Kleich Pérez, Monique Kerstens, Paul Cos
Pages: 978 - 984 - Catechol pyrazolinones as trypanocidals(2012)
Authors: Kristina Maria Orrling, Chimed Jansen, Xuan Lan Vu, Paul Cos, et al.
Pages: 8745 - 8756 - Transcript and protein analysis reveals better survival skills of monocyte-derived dendritic cells compared to monocytes during oxidative stress(2012)
Authors: Ilse Van Brussel, Dorien Schrijvers, Wim Martinet, Isabel Pintelon, Maartje Deschacht, Kathy Schnorbusch, Louis Maes, Johan Bosmans, Christiaan Vrints, Paul Cos, et al.
- **In vitro** antiprotozoal and cytotoxic activity of 33 ethonopharmacologically selected medicinal plants from DR Congo(2012)
Authors: D. Musuyu Muganza, B.I. Fruth, J. Nzunzu Lami, G.K. Mesia, O.K. Kambu, G.L. Tona, Kanyanga Cimanga, Paul Cos, Louis Maes, Luc Pieters
Pages: 301 - 308 - In vitro antiprotozoal and cytotoxic activity of the aqueous extract, the 80% methanol extract and its fractions from the seeds of **Brucea sumatrana** Roxb. (Simaroubaceae) growing in Democratic Republic of Congo(2012)
Authors: Michel Tshodi Ehata, Adelard Mbenza Phuati, Stanislas Nsaka Lumpu, Kanyanga Cimanga, Paul Cos, Luc Pieters, Louis Maes, Arnold Vlietinck, et al.
Pages: 65 - 71 - In vitro antiprotozoal and cytotoxic activity of **Strychnos variabilis** De Wild (Longaniaceae)(2012)
Authors: A. Mbenza Phuati, S. Nsaka Lumpu, C. Kikweta Munduki, Paul Cos, Kanyanga Cimanga, Jozef Totte, Luc Pieters, Louis Maes, Arnold Vlietinck, et al.
Pages: 31 - 49 - Synthesis and evaluation of the quorum sensing inhibitory effect of substituted triazolyldihydrofuranones(2012)
Authors: Gilles Brackman, Martijn Risseeuw, Shari Celen, Paul Cos, Han J. Nelis, Serge Van Calenbergh, Tom Coenye
Pages: 4737 - 4743
Patents
1 - 5 of 5
- Compositions against candida infections (Inventor)
- Bis(acetamidophenyl) guanidinophenyethylphosphonates for use in the prevention and/or treatment of PAR-related diseases. (Inventor)
- Bis(acetamidophenyl) guanidinophenylethylphosphonates for use in the prevention and/or treatment of par-related diseases (Inventor)
- Compositions against candida infections (Inventor)
- Bis(acetamidophenyl) guanidinophenylethylphosphonates for use in the prevention and/or treatment of par-related diseases (Inventor)
Linked dataset
1 - 1 of 1